HIV Diagnostics Market Size By Product {Antibody Tests [HIV-1 Screening Tests (ELISA/EIA, Home Access Dried Blood Spot, Rapid Tests), HIV-1 Confirmatory Tests (Western Blot Test, Indirect Immunofluorescent Antibody Assay (IFA), Line Immunoassay (Cnf), Radioimmunoprecipitation Assay (RIPA)), HIV-2 & Group O Diagnostic Tests (Blood Antibody Test, Dried Blood Spot (DBS) Test, Line Immunoassay (HIV-2)], Viral Identification Assays (p24 Antigen Tests, Qualitative PCR Tests, Viral Culture), CD4 Testing, Viral Load Testing, Early Infant Diagnosis}, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Dec 2018  |  Report ID: GMI491  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 180   |   Base Year: 2017




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1.  Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2.  Primary

Chapter 2.  Executive Summary

2.1. HIV diagnostics industry 3600 synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Regional trends

Chapter 3.  HIV Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Favorable regulatory landscape in the U.S.

3.3.1.2.  Point-of-care (POC) HIV diagnostics development

3.3.1.3.  Increasing number of blood transfusions and blood donations

3.3.1.4.  Rising AIDS/HIV prevalence in low and middle-income countries

3.3.1.5.  Increasing government initiatives for HIV awareness

3.3.2.  Industry pitfalls and challenges

3.3.2.1.  Low degree of penetration in underdeveloped market

3.4. Growth potential analysis

3.4.1.  By product

3.5. Regulatory landscape

3.6. Technology landscape

3.6.1.  Point of care tests (rapid tests)

3.6.2.  Over-the-counter tests (OTC)

3.7. Reimbursement scenario

3.8. Pricing analysis

3.9. Porter’s analysis

3.10. Competitive landscape, 2017

3.10.1. Strategy dashboard

3.11.    PESTEL analysis

Chapter 4.  HIV Diagnostics Market, By Product

4.1. Key segment trends

4.2. Antibody tests

4.2.1.  Market size, by region, 2013-2024 (USD Million)

4.2.2.  HIV-1 screening tests

4.2.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.2.2.    ELISA/EIA

4.2.2.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.2.3. Home access dried blood spot

4.2.2.3.1. Market size, by region, 2013-2024 (USD Million)

4.2.2.4. Rapid tests

4.2.2.4.1. Market size, by region, 2013-2024 (USD Million)

4.2.3.  HIV-1 confirmatory tests

4.2.3.1. Market size, by region, 2013-2024 (USD Million)

4.2.3.2.    Western blot test

4.2.3.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.3.3. Indirect immunofluorescent antibody assay (IFA)

4.2.3.3.1. Market size, by region, 2013-2024 (USD Million)

4.2.3.4. Line immunoassay (Cnf)

4.2.3.4.1. Market size, by region, 2013-2024 (USD Million)

4.2.3.5. Radioimmunoprecipitation assay (RIPA)

4.2.3.5.1. Market size, by region, 2013-2024 (USD Million)

4.2.4.  HIV-2 & Group O diagnostic tests

4.2.4.1. Market size, by region, 2013-2024 (USD Million)

4.2.4.2.    Blood antibody test

4.2.4.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.4.3. Dried blood spot (DBS) test

4.2.4.3.1. Market size, by region, 2013-2024 (USD Million)

4.2.4.4. Line immunoassay (HIV-2)

4.2.4.4.1. Market size, by region, 2013-2024 (USD Million)

4.2.4.5. Others

4.2.4.5.1. Market size, by region, 2013-2024 (USD Million)

4.3. Viral identification assays

4.3.1.  Market size, by region, 2013-2024 (USD Million)

4.3.2.  p24 antigen tests

4.3.2.1. Market size, by region, 2013-2024 (USD Million)

4.3.3.  Qualitative PCR tests

4.3.3.1.    Market size, by region, 2013-2024 (USD Million)

4.3.4.  Viral culture

4.3.4.1. Market size, by region, 2013-2024 (USD Million)

4.4. CD4 testing

4.4.1.  Market size, by region, 2013-2024 (USD Million)

4.5. Viral load testing

4.5.1.  Market size, by region, 2013-2024 (USD Million)

4.6. Early infant diagnosis

4.6.1.  Market size, by region, 2013-2024 (USD Million)

Chapter 5.  HIV Diagnostics Market, By Region

5.1. Key regional trends

5.2. North America

5.2.1.  Market size, by country 2013 – 2024

5.2.2.  Market size, by product, 2013 – 2024

5.2.2.1.    Market size, by antibody tests, 2013 – 2024

5.2.2.1.1.   Market size, by HIV-1 screening tests, 2013 – 2024

5.2.2.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.2.2.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.2.2.2.    Market size, by viral identification assays, 2013 – 2024

5.2.3.  U.S.

5.2.3.1.    Market size, by product, 2013 – 2024

5.2.3.1.1.    Market size, by antibody tests, 2013 – 2024

5.2.3.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.2.3.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.2.3.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.2.3.1.2.    Market size, by viral identification assays, 2013 – 2024

5.2.4.  Canada

5.2.4.1.    Market size, by product, 2013 – 2024

5.2.4.1.1.    Market size, by antibody tests, 2013 – 2024

5.2.4.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.2.4.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.2.4.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.2.4.1.2.    Market size, by viral identification assays, 2013 – 2024

5.3. Europe

5.3.1.  Market size, by country 2013 – 2024

5.3.2.  Market size, by product, 2013 – 2024

5.3.2.1.    Market size, by antibody tests, 2013 – 2024

5.3.2.1.1.   Market size, by HIV-1 screening tests, 2013 – 2024

5.3.2.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.3.2.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.3.2.2.    Market size, by viral identification assays, 2013 – 2024

5.3.3.  Germany

5.3.3.1.    Market size, by product, 2013 – 2024

5.3.3.1.1.    Market size, by antibody tests, 2013 – 2024

5.3.3.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.3.3.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.3.3.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.3.3.1.2.    Market size, by viral identification assays, 2013 – 2024

5.3.4.  UK

5.3.4.1.    Market size, by product, 2013 – 2024

5.3.4.1.1.    Market size, by antibody tests, 2013 – 2024

5.3.4.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.3.4.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.3.4.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.3.4.1.2.    Market size, by viral identification assays, 2013 – 2024

5.3.5.  Italy

5.3.5.1.    Market size, by product, 2013 – 2024

5.3.5.1.1.    Market size, by antibody tests, 2013 – 2024

5.3.5.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.3.5.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.3.5.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.3.5.1.2.    Market size, by viral identification assays, 2013 – 2024

5.3.6.  France

5.3.6.1.    Market size, by product, 2013 – 2024

5.3.6.1.1.    Market size, by antibody tests, 2013 – 2024

5.3.6.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.3.6.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.3.6.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.3.6.1.2.    Market size, by viral identification assays, 2013 – 2024

5.3.7.  Spain

5.3.7.1.    Market size, by product, 2013 – 2024

5.3.7.1.1.    Market size, by antibody tests, 2013 – 2024

5.3.7.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.3.7.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.3.7.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.3.7.1.2.    Market size, by viral identification assays, 2013 – 2024

5.3.8.  Russia

5.3.8.1.    Market size, by product, 2013 – 2024

5.3.8.1.1.    Market size, by antibody tests, 2013 – 2024

5.3.8.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.3.8.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.3.8.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.3.8.1.2.    Market size, by viral identification assays, 2013 – 2024

5.4. Europe

5.4.1.  Market size, by country 2013 – 2024

5.4.2.  Market size, by product, 2013 – 2024

5.4.2.1.    Market size, by antibody tests, 2013 – 2024

5.4.2.1.1.   Market size, by HIV-1 screening tests, 2013 – 2024

5.4.2.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.4.2.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.4.2.2.    Market size, by viral identification assays, 2013 – 2024

5.4.3.  Japan

5.4.3.1.    Market size, by product, 2013 – 2024

5.4.3.1.1.    Market size, by antibody tests, 2013 – 2024

5.4.3.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.4.3.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.4.3.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.4.3.1.2.    Market size, by viral identification assays, 2013 – 2024

5.4.4.  China

5.4.4.1.    Market size, by product, 2013 – 2024

5.4.4.1.1.    Market size, by antibody tests, 2013 – 2024

5.4.4.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.4.4.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.4.4.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.4.4.1.2.    Market size, by viral identification assays, 2013 – 2024

5.4.5.  India

5.4.5.1.    Market size, by product, 2013 – 2024

5.4.5.1.1.    Market size, by antibody tests, 2013 – 2024

5.4.5.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.4.5.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.4.5.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.4.5.1.2.    Market size, by viral identification assays, 2013 – 2024

5.5. Latin America

5.5.1.  Market size, by country 2013 – 2024

5.5.2.  Market size, by product, 2013 – 2024

5.5.2.1.    Market size, by antibody tests, 2013 – 2024

5.5.2.1.1.   Market size, by HIV-1 screening tests, 2013 – 2024

5.5.2.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.5.2.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.5.2.2.    Market size, by viral identification assays, 2013 – 2024

5.5.3.  Brazil

5.5.3.1.    Market size, by product, 2013 – 2024

5.5.3.1.1.    Market size, by antibody tests, 2013 – 2024

5.5.3.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.5.3.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.5.3.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.5.3.1.2.    Market size, by viral identification assays, 2013 – 2024

5.5.4.  Mexico

5.5.4.1.    Market size, by product, 2013 – 2024

5.5.4.1.1.    Market size, by antibody tests, 2013 – 2024

5.5.4.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.5.4.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.5.4.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.5.4.1.2.    Market size, by viral identification assays, 2013 – 2024

5.6. MEA

5.6.1.  Market size, by country 2013 – 2024

5.6.2.  Market size, by product, 2013 – 2024

5.6.2.1.    Market size, by antibody tests, 2013 – 2024

5.6.2.1.1.   Market size, by HIV-1 screening tests, 2013 – 2024

5.6.2.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.6.2.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.6.2.2.    Market size, by viral identification assays, 2013 – 2024

5.6.3.  South Africa

5.6.3.1.    Market size, by product, 2013 – 2024

5.6.3.1.1.    Market size, by antibody tests, 2013 – 2024

5.6.3.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.6.3.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.6.3.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.6.3.1.2.    Market size, by viral identification assays, 2013 – 2024

5.6.4.  Saudi Arabia

5.6.4.1.    Market size, by product, 2013 – 2024

5.6.4.1.1.    Market size, by antibody tests, 2013 – 2024

5.6.4.1.1.1.  Market size, by HIV-1 screening tests, 2013 – 2024

5.6.4.1.1.2.   Market size, by HIV-1 confirmatory tests, 2013 – 2024

5.6.4.1.1.3.   Market size, by HIV-2 & group O diagnostic tests, 2013 – 2024

5.6.4.1.2.    Market size, by viral identification assays, 2013 – 2024

Chapter 6.  Company Profiles

6.1.    Abbott

6.1.1.  Business overview

6.1.2.  Financial data

6.1.3.  Product landscape

6.1.4.  Strategic outlook

6.1.5.  SWOT analysis

6.2.    Apogee Flow Systems Ltd.

6.2.1.  Business overview

6.2.2.  Financial data

6.2.3.  Product landscape

6.2.4.  Strategic outlook

6.2.5.  SWOT analysis

6.3.    atomo diagnostics

6.3.1.  Business overview

6.3.2.  Financial data

6.3.3.  Product landscape

6.3.4.  Strategic outlook

6.3.5.  SWOT analysis

6.4.    BD Biosciences

6.4.1.  Business overview

6.4.2.  Financial data

6.4.3.  Product landscape

6.4.4.  Strategic outlook

6.4.5.  SWOT analysis

6.5.    Beckman Coulter Inc.

6.5.1.  Business overview

6.5.2.  Financial data

6.5.3.  Product landscape

6.5.4.  Strategic outlook

6.5.5.  SWOT analysis

6.6.    BioMerieux SA

6.6.1.  Business overview

6.6.2.  Financial data

6.6.3.  Product landscape

6.6.4.  Strategic outlook

6.6.5.  SWOT analysis

6.7.    Cepheid

6.7.1.  Business overview

6.7.2.  Financial data

6.7.3.  Product landscape

6.7.4.  Strategic outlook

6.7.5.  SWOT analysis

6.8.   ChemBio Diagnostics Inc.

6.8.1.  Business overview

6.8.2.  Financial data

6.8.3.  Product landscape

6.8.4.  Strategic outlook

6.8.5.  SWOT analysis

6.9.   Daktari Diagnostics, Inc.

6.9.1.  Business overview

6.9.2.  Financial data

6.9.3.  Product landscape

6.9.4.  Strategic outlook

6.9.5.  SWOT analysis

6.10. Hologic Inc.

6.10.1. Business overview

6.10.2. Financial data

6.10.3. Product landscape

6.10.4. Strategic outlook

6.10.5. SWOT analysis

6.11. Merck KGaA

6.11.1. Business overview

6.11.2. Financial data

6.11.3. Product landscape

6.11.4. Strategic outlook

6.11.5. SWOT analysis

6.12. PointCare Technologies, Inc.

6.12.1. Business overview

6.12.2. Financial data

6.12.3. Product landscape

6.12.4. Strategic outlook

6.12.5. SWOT analysis

6.13. Qiagen

6.13.1. Business overview

6.13.2. Financial data

6.13.3. Product landscape

6.13.4. Strategic outlook

6.13.5. SWOT analysis

6.14. Roche Diagnostics

6.14.1. Business overview

6.14.2. Financial data

6.14.3. Product landscape

6.14.4. Strategic outlook

6.14.5. SWOT analysis

6.15. Siemens AG

6.15.1. Business overview

6.15.2. Financial data

6.15.3. Product landscape

6.15.4. Strategic outlook

6.15.5. SWOT analysis

6.16. Sysmex Partec GmbH

6.16.1. Business overview

6.16.2. Financial data

6.16.3. Product landscape

6.16.4. Strategic outlook

6.16.5. SWOT analysis

 

Data Tables

TABLE 1    HIV diagnostics industry 360º synopsis, 2013 – 2024

TABLE 2    HIV diagnostics market, 2013-2017 (USD Million)

TABLE 3    HIV diagnostics market, 2018-2024 (USD Million)

TABLE 4    HIV diagnostics market, by product, 2013-2017 (USD Million)

TABLE 5    HIV diagnostics market, by product, 2018-2024 (USD Million)

TABLE 6    HIV diagnostics market, by region, 2013-2017 (USD Million)

TABLE 7    HIV diagnostics market, by region, 2018-2024 (USD Million)

TABLE 8    Industry impact forces

TABLE 9    Antibody tests market size, by region, 2013-2017 (USD Million)

TABLE 10    Antibody tests market size, by region, 2018-2024 (USD Million)

TABLE 11    HIV-1 screening tests market size, by region, 2013-2017 (USD Million)

TABLE 12    HIV-1 screening tests market size, by region, 2018-2024 (USD Million)

TABLE 13    ELISA/EIA market size, by region, 2013-2017 (USD Million)

TABLE 14    ELISA/EIA market size, by region, 2018-2024 (USD Million)

TABLE 15    Home access dried blood spot market size, by region, 2013-2017 (USD Million)

TABLE 16    Home access dried blood spot market size, by region, 2018-2024 (USD Million)

TABLE 17    Rapid tests market size, by region, 2013-2017 (USD Million)

TABLE 18    Rapid tests market size, by region, 2018-2024 (USD Million)

TABLE 19    HIV-1 confirmatory tests market size, by region, 2013-2017 (USD Million)

TABLE 20    HIV-1 confirmatory tests market size, by region, 2018-2024 (USD Million)

TABLE 21    Western blot test market size, by region, 2013-2017 (USD Million)

TABLE 22    Western blot test market size, by region, 2018-2024 (USD Million)

TABLE 23    IFA market size, by region, 2013-2017 (USD Million)

TABLE 24    IFA market size, by region, 2018-2024 (USD Million)

TABLE 25    Line immunoassay (Cnf) market size, by region, 2013-2017 (USD Million)

TABLE 26    Line immunoassay (Cnf) market size, by region, 2018-2024 (USD Million)

TABLE 27    RIPA market size, by region, 2013-2017 (USD Million)

TABLE 28    RIPA market size, by region, 2018-2024 (USD Million)

TABLE 29    HIV-2 & group O diagnostic tests market size, by region, 2013-2017 (USD Million)

TABLE 30    HIV-2 & group O diagnostic tests market size, by region, 2018-2024 (USD Million)

TABLE 31    Blood antibody test market size, by region, 2013-2017 (USD Million)

TABLE 32    Blood antibody test market size, by region, 2018-2024 (USD Million)

TABLE 33    DBS test market size, by region, 2013-2017 (USD Million)

TABLE 34    DBS test market size, by region, 2018-2024 (USD Million)

TABLE 35    Line immunoassay (HIV-2) market size, by region, 2013-2017 (USD Million)

TABLE 36    Line immunoassay (HIV-2) market size, by region, 2018-2024 (USD Million)

TABLE 37    Others market size, by region, 2013-2017 (USD Million)

TABLE 38    Others market size, by region, 2018-2024 (USD Million)

TABLE 39    Viral identification assays market size, by region, 2013-2017 (USD Million)

TABLE 40    Viral identification assays market size, by region, 2018-2024 (USD Million)

TABLE 41    p24 antigen tests market size, by region, 2013-2017 (USD Million)

TABLE 42    p24 antigen tests market size, by region, 2018-2024 (USD Million)

TABLE 43    Qualitative PCR tests market size, by region, 2013-2017 (USD Million)

TABLE 44    Qualitative PCR tests market size, by region, 2018-2024 (USD Million)

TABLE 45    Viral culture market size, by region, 2013-2017 (USD Million)

TABLE 46    Viral culture market size, by region, 2018-2024 (USD Million)

TABLE 47    CD4 testing market size, by region, 2013-2017 (USD Million)

TABLE 48    CD4 testing market size, by region, 2018-2024 (USD Million)

TABLE 49    Viral load testing market size, by region, 2013-2017 (USD Million)

TABLE 50    Viral load testing market size, by region, 2018-2024 (USD Million)

TABLE 51    Early infant diagnosis market size, by region, 2013-2017 (USD Million)

TABLE 52    Early infant diagnosis market size, by region, 2018-2024 (USD Million)

TABLE 53    North America HIV diagnostics market size, by country, 2013-2017 (USD Million)

TABLE 54    North America HIV diagnostics market size, by country, 2018-2024 (USD Million)

TABLE 55    North America HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 56    North America HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 57    North America HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 58    North America HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 59    North America HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 60    North America HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 61    North America HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 62    North America HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 63    North America HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 64    North America HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 65    North America HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 66    North America HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 67    U.S. HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 68    U.S. HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 69    U.S. HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 70    U.S. HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 71    U.S. HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 72    U.S. HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 73    U.S. HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 74    U.S. HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 75    U.S. HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 76    U.S. HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 77    U.S. HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 78    U.S. HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 79    Canada HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 80    Canada HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 81    Canada HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 82    Canada HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 83    Canada HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 84    Canada HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 85    Canada HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 86    Canada HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 87    Canada HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 88    Canada HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 89    Canada HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 90    Canada HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 91    Europe HIV diagnostics market size, by country, 2013-2017 (USD Million)

TABLE 92    Europe HIV diagnostics market size, by country, 2018-2024 (USD Million)

TABLE 93    Europe HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 94    Europe HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 95    Europe HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 96    Europe HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 97    Europe HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 98    Europe HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 99    Europe HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 100    Europe HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 101    Europe HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 102    Europe HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 103    Europe HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 104    Europe HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 105    Germany HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 106    Germany HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 107    Germany HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 108    Germany HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 109    Germany HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 110    Germany HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 111    Germany HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 112    Germany HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 113    Germany HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 114    Germany HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 115    Germany HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 116    Germany HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 117    UK HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 118    UK HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 119    UK HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 120    UK HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 121    UK HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 122    UK HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 123    UK HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 124    UK HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 125    UK HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 126    UK HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 127    UK HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 128    UK HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 129    Italy HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 130    Italy HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 131    Italy HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 132    Italy HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 133    Italy HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 134    Italy HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 135    Italy HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 136    Italy HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 137    Italy HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 138    Italy HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 139    Italy HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 140    Italy HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 141    France HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 142    France HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 143    France HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 144    France HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 145    France HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 146    France HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 147    France HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 148    France HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 149    France HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 150    France HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 151    France HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 152    France HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 153    Spain HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 154    Spain HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 155    Spain HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 156    Spain HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 157    Spain HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 158    Spain HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 159    Spain HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 160    Spain HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 161    Spain HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 162    Spain HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 163    Spain HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 164    Spain HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 165    Russia HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 166    Russia HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 167    Russia HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 168    Russia HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 169    Russia HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 170    Russia HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 171    Russia HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 172    Russia HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 173    Russia HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 174    Russia HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 175    Russia HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 176    Russia HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 177    Asia Pacific HIV diagnostics market size, by country, 2013-2017 (USD Million)

TABLE 178    Asia Pacific HIV diagnostics market size, by country, 2018-2024 (USD Million)

TABLE 179    Asia Pacific HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 180    Asia Pacific HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 181    Asia Pacific HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 182    Asia Pacific HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 183    Asia Pacific HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 184    Asia Pacific HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 185    Asia Pacific HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 186    Asia Pacific HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 187    Asia Pacific HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 188    Asia Pacific HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 189    Asia Pacific HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 190    Asia Pacific HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 191    Japan HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 192    Japan HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 193    Japan HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 194    Japan HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 195    Japan HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 196    Japan HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 197    Japan HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 198    Japan HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 199    Japan HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 200    Japan HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 201    Japan HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 202    Japan HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 203    China HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 204    China HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 205    China HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 206    China HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 207    China HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 208    China HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 209    China HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 210    China HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 211    China HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 212    China HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 213    China HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 214    China HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 215    India HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 216    India HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 217    India HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 218    India HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 219    India HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 220    India HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 221    India HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 222    India HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 223    India HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 224    India HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 225    India HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 226    India HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 227    Latin America HIV diagnostics market size, by country, 2013-2017 (USD Million)

TABLE 228    Latin America HIV diagnostics market size, by country, 2018-2024 (USD Million)

TABLE 229    Latin America HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 230    Latin America HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 231    Latin America HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 232    Latin America HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 233    Latin America HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 234    Latin America HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 235    Latin America HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 236    Latin America HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 237    Latin America HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 238    Latin America HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 239    Latin America HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 240    Latin America HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 241    Brazil HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 242    Brazil HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 243    Brazil HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 244    Brazil HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 245    Brazil HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 246    Brazil HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 247    Brazil HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 248    Brazil HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 249    Brazil HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 250    Brazil HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 251    Brazil HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 252    Brazil HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 253    Mexico HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 254    Mexico HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 255    Mexico HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 256    Mexico HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 257    Mexico HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 258    Mexico HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 259    Mexico HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 260    Mexico HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 261    Mexico HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 262    Mexico HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 263    Mexico HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 264    Mexico HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 265    MEA HIV diagnostics market size, by country, 2013-2017 (USD Million)

TABLE 266    MEA HIV diagnostics market size, by country, 2018-2024 (USD Million)

TABLE 267    MEA HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 268    MEA HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 269    MEA HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 270    MEA HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 271    MEA HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 272    MEA HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 273    MEA HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 274    MEA HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 275    MEA HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 276    MEA HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 277    MEA HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 278    MEA HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 279    South Africa HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 280    South Africa HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 281    South Africa HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 282    South Africa HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 283    South Africa HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 284    South Africa HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 285    South Africa HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 286    South Africa HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 287    South Africa HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 288    South Africa HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 289    South Africa HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 290    South Africa HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)

TABLE 291    Saudi Arabia HIV diagnostics market size, by product, 2013-2017 (USD Million)

TABLE 292    Saudi Arabia HIV diagnostics market size, by product, 2018-2024 (USD Million)

TABLE 293    Saudi Arabia HIV diagnostics market size, by antibody tests, 2013-2017 (USD Million)

TABLE 294    Saudi Arabia HIV diagnostics market size, by antibody tests, 2018-2024 (USD Million)

TABLE 295    Saudi Arabia HIV diagnostics market size, by HIV-1 screening tests, 2013-2017 (USD Million)

TABLE 296    Saudi Arabia HIV diagnostics market size, by HIV-1 screening tests, 2018-2024 (USD Million)

TABLE 297    Saudi Arabia HIV diagnostics market size, by HIV-1 confirmatory tests, 2013-2017 (USD Million)

TABLE 298    Saudi Arabia HIV diagnostics market size, by HIV-1 confirmatory tests, 2018-2024 (USD Million)

TABLE 299    Saudi Arabia HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2013-2017 (USD Million)

TABLE 300    Saudi Arabia HIV diagnostics market size, by HIV-2 & group O diagnostic tests, 2018-2024 (USD Million)

TABLE 301    Saudi Arabia HIV diagnostics market size, by viral identification assays, 2013-2017 (USD Million)

TABLE 302    Saudi Arabia HIV diagnostics market size, by viral identification assays, 2018-2024 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global HIV diagnostics market, 2013 - 2024 (USD Million)

FIG. 3    Growth potential analysis, by product

FIG. 4    Porter’s analysis

FIG. 5    Strategy dashboard

FIG. 6    PESTEL Analysis

 

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Dec 2018
  • Pages: 180
  • Tables: 302
  • Charts / Figures: 6
  • Companies covered: 16
  • Countries covered: 15

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X